Life Science Partner recruits former Senior Director, Program Management for Genzyme Corporation
Life Science Partner announces the recruitment of Jane Weiss Doerr, RN, MSN, a seasoned oncology clinical trials executive, to Windy Hill Medical as Director of Clinical Affairs. Windy Hill Medical is a California-based medical device and pharmaceutical company focused on the development of products to reduce the risk of developing breast cancer in patients deemed to be at high risk.
In Doerr’s previous role at Genzyme, a global biotechnology company developing advanced technologies for the treatment of numerous debilitating diseases, she managed a multi-disciplinary global product development team delivering oncology products to the market. Previously, Doerr was Director and Product Team leader for ILEX Oncology, Inc. where she was responsible for numerous oncology products in various stages of development. She also served as Senior Vice President for Oncology Research Partners, a national network of academic and community physicians focused on cancer care.
“Jane has a wealth of experience in the oncology clinical and biopharmaceutical industry and is well-grounded as a strategic thinker and operational leader,” noted Tom Callaway, MD, founder and president of Life Science Partner. “She is very passionate about bringing lasting improvements in healthcare for patients with cancer.”
In her role as Director of Clinical Affairs, Doerr will have the responsibility for managing all phases of Windy Hill’s global clinical trials for the expanding portfolio of compounds under development. She will collaborate with academic thought leaders, provide strategic direction to the company and build a world-class clinical development team with an eye toward successful FDA and European approvals.
Doerr earned her Bachelor of Science in Nursing at the University of Texas Health Science Center School of Nursing in San Antonio, Texas. She received a Master of Science in Nursing from the University’s Graduate School of Biomedical Sciences.